Home/Pipeline/REC603

REC603

HPV Prevention (9-valent)

Phase 3Active

Key Facts

Indication
HPV Prevention (9-valent)
Phase
Phase 3
Status
Active
Company

About Recbio Technology

A Chinese vaccine innovator with proprietary adjuvant and protein engineering platforms, advancing late-stage HPV and shingles vaccines.

View full company profile

Therapeutic Areas